Like most other cells in the body, foetal and neonatal cardiac myocytes are able to divide and proliferate. However, the ability of these cells to undergo cell division decreases progressively during development such that adult myocytes are unable to divide. A major problem arising from this inability of adult cardiac myocytes to proliferate is that the mature heart is unable to regenerate new myocardial tissue following severe injury, e.g. infarction, which can lead to compromised cardiac pump function and even death. Studies in proliferating cells have identified a group of genes and proteins that controls cell division. These proteins include cyclins, cyclin-dependent kinases (CDKs) and CDK inhibitors (CDKIs), which interact with each other to form complexes that are essential for controlling normal cell cycle progression. A variety of other proteins, e.g. the retinoblastoma protein (pRb) and members of the E2F family of transcription factors, also can interact with, and modulate the activities of, these complexes. Despite the major role that these proteins play in other cell types, little was known until recently about their existence and activities in immature (proliferating) or mature (non-proliferating) cardiac myocytes. The reason(s) why cardiac myocytes lose their ability to divide during development remains unknown, but if strategies were developed to understand the mechanisms underlying cardiac myocyte growth, it could open up new avenues for the treatment of cardiovascular disease. In this article, we shall review the function of the cell cycle machinery and outline some of our recent findings pertaining to the involvement of the cell cycle in modulating cardiac myocyte growth and hypertrophy.
Introduction
where the entire cell contents are duplicated, followed by the cell dividing into two daughter cells) and hypertrophy
Developmental regulation of cardiac myocyte
(an increase in cell size without a concomitant increase in growth cell number), resulting in an overall increase in the mass of the heart [1] . Myocyte proliferation ceases completely by During the early stages of mammalian development, about 17 days post-natal development in the rat, with all cardiac myocytes grow both by hyperplasia (cell division, subsequent increases in heart size being due solely to hypertrophy [1] , although it has been reported recently that the switch from hyperplastic to hypertrophic growth in the Abbreviations: CDK, cyclin-dependent kinase; CDKI, cyclin-depenrat heart occurs between days three and four of post-natal dent kinase inhibitor; pRb, retinoblastoma protein; LVH, left ventricular development [2] . Furthermore, in the mouse, all cardiac hypertrophy; R point, restriction point; TGF-b, transforming growth factor-b; MTS, multiple tumour suppressor; AC, aortic constriction; SH, myocyte cell division has ceased by birth, although DNA sham; LV, left ventricular; FACS, fluorescence-activated cell sorting; synthesis continues in neonatal cells, which contributes to mRNA, messenger ribonucleic acid; PCNA, proliferating cell nuclear myocyte binucleation [3] . The inability of adult cardiac antigen myocytes to proliferate has been attributed to a block in the cell cycle, which occurs shortly after birth [4] . Thus, [11] for review). These include genes encoding for atrial following severe injury, such as occurs during myocardial natriuretic factor [12] , sarcolemmal ion transporting pro- 1 1 infarction, the mature heart is unable to regenerate new teins, such as Na / K ATPase a subunits [13] and the 1 21 myocytes to replace necrotic or damaged tissue. Despite Na / Ca exchanger [11, 14] , and structural proteins, such the diminishing ability of the cardiac myocyte to undergo as b-myosin heavy chain (b-MHC) and skeletal muscle cell division, it is able to synthesise DNA throughout its a-actin [15, 12] , changes in expression of which are the life, if required, which is thought to reflect either the reverse of those observed during post-natal development formation of binucleated cardiomyocytes and / or an in- [11, [16] [17] [18] . However, little is known about those molecrease in the ploidy of the myocyte nuclei, rather than an cules that act upstream and induce these changes in gene increase in cell number, which would require myocyte cell expression during hypertrophic growth, although recent division [5] . In the adult rat heart, there appears to be a findings from our laboratory have demonstrated that cell block in the cell cycle, with the majority of myocytes cycle-dependent molecules may play an important role ( being locked in either the G or G phases of the cell cycle [19] and see below). 0 1 [4] , consistent with terminal differentiation of these cells. However, our recent studies using fluorescence-activated cell sorting (FACS) analysis of propidium iodide-and bromodeoxyuridine-labelled myocyte nuclei have sug-2. The mammalian cell cycle gested that an additional, and significant, block occurs also at the G / M phase of the cell cycle. Thus, whereas 85% of The cell cycle is divided into five distinct phases (see 2 adult myocytes were found in G / G , 15% were found in Fig. 1 diomyogenesis, a significant number of myocytes remain the cell synthesises mRNAs and proteins in readiness for in G , thereby forming a population of G -arrested cells.
DNA synthesis, which occurs during the S phase of the 2 2 In additional studies, Anversa et al. [7] and Olivetti et al. cycle. Following DNA synthesis, the cell enters a second [8] have shown that, in some instances, cardiac myocyte gap phase known as G , when the cell synthesises addi-2 nuclear division can be re-initiated in the adult rat heart. tional mRNAs and proteins in preparation for cell division However, this re-initiation of myocyte nuclear division or mitosis, which occurs during the M phase of the cycle. appears to occur only in decompensated hearts that are Cell cycle progression is known to be under the control of aged or have been subjected to extreme, long term stress cell cycle-dependent molecules and is regulated both and there is no evidence that this phenomenon occurs in positively, through the formation and activation of various normal adult hearts.
cyclin and cyclin-dependent kinase (CDK) complexes, and negatively, by CDK inhibitors (CDKIs; see [20] for 1.2. Left ventricular hypertrophy (LVH): A major risk review). A variety of other proteins, e.g. retinoblastoma factor for cardiovascular morbidity and mortality protein (pRb), proliferating cell nuclear antigen (PCNA) and members of the E2F transcription factor family, also LVH now is recognised widely as a powerful carcan interact with, and modulate the activity of, these diovascular risk factor. Data from the Framingham study complexes. have shown that LVH is associated with all manifestations A number of cell cycle checkpoints exist within the cell of ischaemic heart disease (e.g. myocardial infarction and that are essential for healthy cell division. The primary cell cardiac failure), and that there is a particularly strong cycle checkpoint coordinating cell growth and proliferation association with an increased incidence of sudden cardiac in mammalian cells is called the restriction (R) point and death [9] . Except in the case of cardiomyopathies, cardiac once a cell has passed this point, it is committed to a hypertrophy generally is an adaptive, physiological refurther round of DNA replication (S phase) and cell sponse of the heart to stress, imposed as a result of e.g. division (mitosis), except in fully differentiated cells such hypertension or myocardial infarction [10] . It is important as adult cardiac myocytes, where DNA synthesis can occur to note, however, that the hypertrophic response produced in the absence of cell division. by left ventricular overload is not in itself a pathological
We previously have reviewed the area of cyclins and state, since, as a result of normal development, the heart CDKs in cardiac myocyte development in detail [20] and, undergoes this process. A number of investigators have therefore, will limit this review to a discussion of those shown that cardiac hypertrophy is associated with qualiCDKIs that are expressed in cardiac myocytes and their tative and quantitative changes in the expression of various potential role(s) in mediating cell cycle arrest of developgenes, in many cases, towards the foetal phenotype (see ing cardiac myocytes and in hypertrophic growth. 3. The cyclin-dependent kinase inhibitors (CDKIs) p16 [23, 24] , p18 [21, 25] and p19 [25] , and
CIP1
(ii) the KIP/ CIP family, which includes p21 [26, 27] ,
The CDKIs are a recently described class of cell cycle p27 [28, 29] and p57 [30, 31] . Members of the regulatory molecules that exert a negative effect on the cell KIP/ CIP family are structurally unrelated to the INK4 cycle machinery by binding to, and inhibiting the activities family and, in vitro, the KIP/ CIP family shows a broader of, various cyclin-CDK complexes. Currently, two strucspecificity, since it interacts with, and inhibits the kinase turally defined classes of CDKIs exist in mammals: (i) the activities of, cyclin E-CDK2, cyclin D-CDK4, cyclin
INK4B
INK4 family, which includes p14 [21] , p15 [22] , D-CDK6 and cyclin A-CDK2 complexes (Table 1) 
Overexpression
Causes G phase cell cycle arrest [22, 30, 31, 34, 37, 41, 42] [26,29-34] compared with the INK4 CDKIs that inhibit inhibitors as p14, p15, p16, p18, p19, p21, p27 and p57 CDK4 and CDK6 complexes only (Table 1) . Furthermore, (representing the molecular weights of the proteins as the aligned amino acid sequence identities have been measured by polyacrylamide gel electrophoresis). The two determined previously for both the INK4 [21, 22, 25, 35] and families of CDKI molecules display different properties the KIP/ CIP [23, 30, 31, 34, [36] [37] [38] [39] [40] CDKIs and have reand targets, which are summarised in Tables 1 and 2  vealed little sequence homology between the two families. below. Interestingly, no INK4 family members were However, within each family there is high sequence detected at the protein level in cardiac myocytes at any homology, especially at the amino terminus, which constage of development (Poolman and Brooks, unpublished tains the CDK binding site. For example, within the observations); therefore, in this review, we will limit our KIP1 KIP/ CIP family, p27 shows 44 and 47% identity to discussion to those members of the KIP/ CIP family that CIP1 KIP2 CIP1 p21 and p57 , respectively, whereas p21 is 36% are expressed in cardiac myocytes. Further details of the KIP2 identical to p57 within the N-terminal portion of each INK4 family members can be found in several excellent protein [30, 34] . Primarily the CDKIs cause cell cycle reviews (e.g. [43] ). arrest in the G phase of the cell cycle [41, 42] and this is 1 consistent with the proposed block in the cell cycle seen in 3.1. p21 rat cardiac myocytes beyond 17 days of post-natal development [4] . The nomenclature of the CDKIs is com-
The first member of the KIP/ CIP family to be identified plex, due to identification of these molecules by several and cloned was the heat-stable protein, p21 [26, 32, 36 ,44-independent groups, but, for clarity, we shall refer to the 47] . This CDKI appears to be a universal inhibitor of cyclin-CDK activity [26, 33, 44] , primarily acting in G acetate) that often result in G arrest [54, 60, [71] [72] [73] . Thus, 1 1 and at the G -S phase transition (Fig. 1) . As with all p21 appears to function via two opposing mechanisms: (i) 1 CDKI molecules, the cyclin-CDK binding sites are found as a CDKI (p53-dependent) and (ii) as an immediate early at the N-terminus of the p21 molecule [37, 48, 49] , although gene that is induced in response to mitogens and differena second weaker cyclin-binding motif has been discovered tiation stimuli (p53-independent). Given the multiple roles recently in the C-terminal region of p21 [50] . In normal and universal effects of p21 in the cell, it was expected that cells, p21 exists primarily in a quaternary complex with a the deletion of the p21 gene would result in disastrous cyclin, a CDK and PCNA [33, 38, 51] . PCNA is a nuclear consequences. However, in comparison to p27 knockout protein that is essential for DNA replication and repair by mice (see Section 3.2), p21 knockout mice developed quite DNA polymerase d and it has been shown that the Cnormally and showed no spontaneous malignancies during terminal domain of p21 can directly inhibit DNA replicaseven months of post-natal observation [74] . The lack of tion, but not repair, by binding to and inhibiting PCNA tumour formation in these mice was consistent with the activity [48, 49, 52] . Thus, p21 can exist in both active and failure to detect p21 gene mutations in a variety of human inactive cyclin-CDK complexes and it has been suggested tumours [75] . The results of these p21 knockout mouse that multiple p21 subunits are required to inhibit cyclinstudies suggest that the role of p21 in terminal differentia-CDK activity [53] . In support of this hypothesis, Zhang et tion and exit of cells from the cell cycle must be redundant al. [53] have shown recently that p21 exists both in in the mouse. However, a potential role for p21 in cardiac catalytically active and inactive cyclin-CDK complexes myocyte cell cycle withdrawal in the rat still remains a and that the addition of subsaturating concentrations of p21 distinct possibility, since protein levels and kinase inhibto cyclin A-CDK2 complexes resulted in a progressive itory activity increase significantly during development, increase in CDK2 activity, suggesting that low concensuch that levels in adult myocytes are more than five-fold trations of p21 might function as a cyclin-CDK assembly greater than in foetal cells ( [76] and Poolman et al. factor, whereas the binding of more than one p21 molecule submitted; see Section 4 below). is apparently required to inhibit CDK2 activity [53] . The association of p21 with PCNA occurs only in non-trans-3.2. p27 formed cells, since the quaternary complexes are disrupted, and p21 and PCNA are no longer bound, in transformed
The p27 protein was first discovered in TGF-b-arrested cells [33, 38, 51] .
mink lung Mv1Lu cells following contact inhibition-meThe level of p21 mRNA has been shown to fluctuate diated G1 arrest of these cells [28] . p27 is highly homoloduring the cell cycle, peaking on exit from the G phase gous to other members of the KIP/ CIP family, with the 0 [36, 38] and at the G / M transition [38] . It has been highest degree of homology being present in the N-termi- 2 proposed that the induction of p21 on exit from G is to nal half of each molecule, where the CDK binding domain 0 reduce cyclin-CDK activity in G and to act as a is found ( threshold, above which cyclin-CDK complexes need to recently solved the crystal structure of a complex between accumulate to enable cell cycle progression [38] . In CDK2-cyclin A and p27 and showed that p27 extended support of this hypothesis, the levels of p21 mRNA and across both the cyclin and the CDK. In comparison to the protein are elevated in quiescent and differentiated cells universal inhibitory effects of p21, p27 is more selective, [38, [54] [55] [56] [57] [58] [59] [60] [61] [62] and overexpression of p21 caused either a cell such that it inhibits CDK2-and CDK4-containing comcycle delay or prevented cellular proliferation plexes only (Fig. 1, Table 2 ) [29, 34, 79] , although it has [33, 37, 44, [63] [64] [65] . Furthermore, expression of antisense been shown to possess weak inhibitory activity against p21 RNA in G -arrested HCA2 human diploid fibroblasts CDC2 [29, 34, 79] and CDK6 [29] . The p27 protein is 198 0 resulted in the induction of DNA synthesis as well as entry amino acids long and, in common with p21, is a heatinto mitosis [39] . Taken together, these results suggest that stable protein [34, 79, 80] , the levels of which were shown decreased expression of the p21 gene is necessary for cell to be elevated in quiescent cells compared to those in cycle progression. Initial studies suggested that regulation proliferating cells [28, 54, [79] [80] [81] [82] [83] [84] . The abundance of p27 of p21 expression was dependent solely upon the tumour protein has been shown to be regulated both by the rate of suppressor, p53, which induces transcription of the p21 p27 translation [80, 83] and by the rate of degradation of gene, thereby causing cell cycle arrest and growth suppresp27 protein by the ubiquitin-proteasome pathway [85] . In sion [33, 52, 55, [66] [67] [68] . However, subsequent studies have contrast to p27 protein levels, mRNA expression of this demonstrated that p21 can be activated also in a p53-CDKI was shown to be similar in both proliferating and independent manner in response to multiple mitogenic quiescent cells [34, 54] . The importance of p27 in cell cycle stimuli [e.g. platelet-derived growth factor, epidermal control was emphasised recently in a study to determine growth factor, fibroblast growth factor and transforming the effects of homozygous deletion of the p27 gene in the growth factor-b (TGF-b) [55, 69, 70] ] and differentiationmouse [86] [87] [88] . Homozygous p272 / 2 mice were shown inducing factors (e.g. okadaic acid, vitamin D3, retinoic to be larger than their normal heterozygous litter mates, acid, dimethyl sulphoxide and phorbol 12-myristate 13- such that a proportional enlargement of many organs of the body was detected, including the heart [86] [87] [88] . This organ development. p27 was expressed at detectable levels in enlargement was shown to be due to an increase in cell both whole ventricular tissue and in isolated cardiac number, rather than an increase in cell size, thereby myocytes, although overall expression of this CDKI in making this model an ideal system for determining the myocytes appeared to be lower than p21 and the extent of effects of this CDKI on the cardiac myocyte cell cycle.
upregulation of p27 expression in cardiac myocytes during Studies currently are underway in our laboratory to investimaturation was shown to be less (|two-fold) than that gate this further.
observed for p21 (|five-fold) (Poolman et al. submitted).
In subsequent experiments, we have shown that both p21 3.3. p57 and p27 are expressed in the nuclei of cardiac myocytes [19] . Burton et al. [90] have shown recently that p57 The most recently described KIP/ CIP CDKI protein is protein expression peaks around day 15 of foetal developp57 [30, 31] . Mouse p57 possesses four structurally distinct ment in the rat and that levels then decline rapidly, such domains; an amino terminal CDK inhibitory domain, a that p57 protein is not detectable after day 19 of foetal proline-rich domain, an acidic domain and a carboxy development. Lee et al. [30] showed that p57 was exterminal domain, which contains a putative nuclear localipressed at the mRNA level in a tissue-specific manner, sation signal and a CDK consensus phosphorylation site such that a 7-kb mRNA species was observed in human [30] . It should be noted that this unique domain structure skeletal muscle and in heart tissue [30] . However, whether was not conserved in human p57 [31] . p57 has been shown p57 protein was present in these tissues was not docuto be a potent inhibitor of G1 and S phase CDK complexes mented. In accordance with our findings, Koh and col-(cyclin D-CDK4 and cyclin E /A-CDK2, respectively; leagues also have evidence for the developmental regula- Table 2 ) but displays less inhibitory activity towards the tion of KIP/ CIP CDKIs during development of the rat mitotic cyclin B-CDC2 complex [30, 31] . p57 protein cardiac myocyte (Koh G-Y, personal communication) and localizes to the nucleus and has been shown to be highly Flink et al. [91] have reported that p21 and p27 inhibitory expressed in a wide range of human tissues, including activities increased markedly in cultured neonatal (twoskeletal muscle, brain, heart, lungs and eye [30, 31] .
day-old) cardiac myocytes when compared to cultured Whereas overexpression of p57 has been shown to cause foetal (16 days gestation) cells [91] . G arrest [30, 31] , mice lacking the imprinted p57 gene
Given that the predominant function of p21 is to inhibit 1 recently have been shown to possess altered cell proliferthe activity of a plethora of cyclin-CDK complexes ation and differentiation, leading to abdominal muscle [26, 33, 44] , we recently have extended our initial studies defects, cleft palate, endochondral bone ossification defects and shown that a heat-stable protein lysate containing p21 with incomplete differentiation of hypertrophic chonprotein, obtained from adult myocytes, was able to inhibit drocytes, renal medullary dysplasia, adrenal cortical hysignificantly the histone H1 kinase activity of CDK2 perplasia and cytomegaly, and lens cell hyperproliferation obtained from neonatal rat cardiac myocyte lysates. In and apoptosis [89] . Indeed, loss of p57 expression has been addition, we have shown that immunodepletion of p21 proposed to play a pivotal role in Beckwith-Wiedemann from these adult myocyte lysates, prior to incubation with syndrome, a pleiotropic hereditary disorder characterised neonatal myocyte lysates, led to a loss of inhibitory by overgrowth and a predisposition to cancer, since these activity (Poolman et al., submitted). Therefore, it is patients display many of the phenotypic changes observed feasible that the up-regulation of the KIP/ CIP family of in p572 / 2 mice. CDKI molecules, especially p21, during cardiac myocyte development could contribute to the progressive withdrawal of maturing cardiac myocytes from the cell cycle.
Expression of CDKI molecules during cardiac
Current work in this area is focussing upon the determimyocyte development nation of the mechanisms involved in p21 up-regulation in the developing cardiac myocyte. As a result of an extensive developmental study using cardiac myocytes obtained from foetal (18 days gestation), neonatal (two-day-old) and adult rats, we were unable to demonstrate expression of any INK4 CDKI family mem-5. Possible role of CDKIs in mediating cardiac bers, despite detection of these molecules in control cell myocyte growth during development lines (Poolman and Brooks, unpublished observations). In contrast, we were able to demonstrate differential expres-
The precise mechanisms that control the cardiac sion of certain KIP/ CIP CDKIs during development of the myocyte cell cycle and, therefore, regulate myocyte prolifrat myocardium [76] . Thus, in more than six separate eration and differentiation still remain to be fully underexperiments, we showed that both whole ventricular tissue stood. However, our recent studies of certain inhibitory and isolated cardiac myocytes displayed a significant elements of the cell cycle (p21 and p27) suggest that upregulation in p21 mRNA and protein expression during certain CDKIs, especially p21, are crucial for controlling the progressive withdrawal of cardiac myocytes from the results in the loss of induction of S phase genes, with a cell cycle during development.
subsequent block in the cell cycle prior to S phase entry. It It is known that the major function of all CDKI is possible, therefore, that, during normal development of molecules is to inhibit the activity of cyclin-CDK comthe rat cardiac myocyte, p21 may contribute to the plexes and that the precise way in which this is achieved progressive loss of myocyte proliferation by inhibiting the depends upon whether KIP/ CIP or INK4 CDKI molecules transcriptional activity of E2F-1. In support of this hypothare involved (Table 1) . Thus, the KIP/ CIP family of CDKI esis, we have shown recently that expression of E2F-1 molecules inhibit intact cyclin-CDK complexes, whereas protein is down-regulated significantly during myocyte INK4 family members prevent the association of cyclins development such that highest levels are found in foetal with their respective CDK partners. The block in the and neonatal myocytes, with levels being undetectable in cardiac myocyte cell cycle (at three-four days post-natal adult cells (Naseem and Brooks, unpublished). development in the rat [2] ) was previously reported to occur during G [4] and, in accordance with this, we have 1 shown that over 85% of adult cardiac myocytes are found 6. Possible role of CDKIs in mediating cardiac in the G or G phases of the cell cycle [76] . However, our myocyte hypertrophy 0 1 recent studies, using FACS analysis of myocyte nuclei, have suggested that a dual mechanism of myocyte cell In addition to determining changes in cell cycle-depencycle arrest exists, with a significant G / M-phase blockade dent molecules during normal myocyte development, we 2 in adult myocytes [76, 92] , supporting a hypothesis proalso have monitored the expression of these molecules posed previously by Rumyantsev [6] , suggesting that a during the development of cardiac hypertrophy. Thus, we population of myocytes begins to arrest during the prenatal have determined p21 and p27 mRNA and protein expresstages of cardiac development. Since p21 and p27 were the sion during the development of pressure overload-induced only two CDKIs detected in myocytes (see Section 4 LVH in the rat [19] and shown that there was a significant, above) and that these molecules can inhibit the activity of but transient, down-regulation in the mRNA and protein G phase CDKs (Fig. 1) and potentially cause a G -phase expression of these two CDKIs during the 3-14 day 1 1 cell cycle arrest, it is possible that one or both of these post-operative period in LV tissue of rats that had undermolecules are involved in arresting adult cardiac myocytes.
gone aortic constriction (AC) compared with sham (SH)-In addition, since p21 mRNA has been shown to peak at operated control animals. Levels of p21 and p27 in aortic the G / M phase, as well as on exit from G [38] , and that constriction (AC) rat hearts subsequently returned to SH 2 0 p21 can inhibit the activity of the G / M-phase CDK, levels by 21 days following operation. Immunocytochemi-2 CDC2, [26, 33, 44] , it is possible that p21 also is critical for cal analyses of LV cryosections demonstrated that this arrest of adult myocytes in the G / M phase of the cell down-regulation of p21 and p27 protein levels during the 2 cycle. development of LVH occurred in myocyte nuclei speRecent observations from our laboratory indicate that, in cifically [19] . Recently, additional studies have shown that addition to an upregulation in the expression and inhibitory the expression and activities of certain positive regulators activities of p21 and p27, there is a concomitant downof the cell cycle are up-regulated concomitant with the regulation in the expression and activities of G -phase down-regulation of p21 and p27 during the development of 1 CDKs during development of the rat cardiac myocyte LVH [99] . Thus, activities and protein expression of the G 1 [20, 93, 94] . Thus, it is conceivable that the up-regulation of CDKs, CDK4 and CDK6, were up-regulated by seven days the KIP/ CIP CDKIs during normal development contripost-operation, with levels returning to those seen in SHbutes to the down-regulation of residual G -phase CDK operated controls by six weeks post-operation. Therefore, 1 activity, leading to the arrest of cardiac myocytes in the G the cardiac myocyte appears to reinitiate a foetal pro-1 phase of the cell cycle. However, other potential functions gramme of cell cycle regulatory molecule gene and protein of CDKI molecules exist, especially for p21, which may be expression during the development of LVH in a similar involved in the withdrawal of cardiac myocytes from the manner to that reported for certain other genes (see Section cell cycle. For example, p21 has been shown to inhibit the 1.2 above). activity of PCNA [95] , leading to cell cycle arrest at, or Interestingly, the changes in expression of both positive just prior to, the S phase. However, we and others have and negative regulators of the cell cycle observed during shown that expression of PCNA is down-regulated during the development of LVH occurred during the adaptive development of the cardiac myocyte [5, 96] and, therefore, growth phase of the LV following pressure overload, such it is unlikely that p21 acts via PCNA to induce a G arrest that the LV weight / body weight ratio plateaued at its 1 in these cells. maximum value (|50% increase in LV mass) approximateRecently, it has been shown that p21 can suppress the ly 21 days following AC, corresponding to the period transcriptional activity of E2F-1 [97] , a transcription factor when the changes in expression of cell cycle regulatory that is essential for the induction of several S phase genes, molecules had returned to control values. Thus, an alterae.g. cyclin A [98] . The suppression of E2F-1 activity tion in the balance of positive-negative cell cycle regula-tory molecule expression appears to be crucial for the the necessary mRNAs and proteins for hypertrophic adaptive growth of the LV (and, specifically, the myocyte) growth, some will enter the S phase and undergo DNA during the development of LVH. Therefore, manipulation synthesis and binucleation [1] [2] [3] [4] [5] 20] . Since, by definition, of the expression of these molecules could offer alternative the hypertrophied myocyte is unable to undergo mitosis, targets for treatment of LVH occurring as a result of any cells that enter the S phase must arrest in G , where 2 myocardial stress or ischaemic heart disease. we propose that the balance of positive:negative regulators returns to that seen in normal adult myocytes (Fig. 2) . In 6.1. Hypothesis for the involvement of cell cycle support of this hypothesis, we have shown that the changes regulatory molecules in the development of LVH in protein expression and activities of cell cycle regulatory molecules following the imposition of pressure overload is In order to explain cardiac myocyte growth by hytransient and that they return to control levels when the pertrophy in terms of cell cycle control, we have formuadaptive LV growth is completed. Furthermore, FACS lated the following hypothesis (see Fig. 2 ). We propose that analyses have shown that the number of myocytes arrestthe majority of normal adult cardiac myocytes are arrested ing in G is enhanced significantly during the development FACS analysis [76] . Consistent with this G arrest, we the G phase of the cycle 14 days after AC operation, 1 2 have shown a decrease in the expression and activities of whereas only |15% of untreated or SH cells are found in certain positive regulators of the cell cycle (cyclins and G at this same time point [99] . 2 CDKs) in adult myocytes, compared with levels found in foetal or neonatal cells, concomitant with an upregulation in the expression of p21 and p27 KIP/ CIP CDKI mole-7. Summary cules [76, 93] . In order for hypertrophic growth to occur, the cell must proceed through G to synthesise certain
The precise mechanism(s) by which cell cycle-depen-1 mRNAs and proteins that are necessary for DNA synthesis dent molecules cause a progressive withdrawal of cardiac or binucleation [1] [2] [3] [4] [5] 20] . In order for this to occur, the myocytes from the cell cycle remains to be determined. cyclin-CDK:CDKI ratios must alter, such that the acHowever, by carefully dissecting the possible molecules tivities of certain positive regulators override the inhibitory involved, we hope to understand fully the mechanisms effects of the CDKIs (Fig. 2) . Our recent studies have involved in cardiac myocyte growth. Certainly, our initial demonstrated that such an effect occurs transiently, but findings suggest that certain CDKI molecules play a significantly, during the development of pressure overloadpivotal role by acting as a ''brake'', which results in induced LVH, since mRNA and protein levels of p21 and cardiac myocyte cell cycle arrest during development. p27 were down-regulated during the active LV growth Furthermore, we have demonstrated that the expression of phase (3-14 days after the imposition of pressure overcertain CDKIs is tightly regulated during the development load) [19] . Moreover, we have demonstrated recently a of LVH, thereby implicating these molecules in this concomitant upregulation in the expression and activities process also. Manipulation of the expression of these of certain cyclin-CDK complexes during this period of LV molecules by antisense technology and / or overexpression growth that is consistent with cell cycle progression during of positive regulators in adult myocytes may enable us to the development of LVH [99] . Once cells have synthesised overcome the block in cell cycle progression, such that we can reinitiate cell division in these cells in a controlled manner. Such an approach could be invaluable in encouraging healthy myocytes that surround an infarcted area to repopulate a damaged myocardial zone.
